Open Access NewsNews from the open access movement Jump to navigation |
|||
Jan Velterop has written a detailed response to Arie Jongejan's October remarks on open access. Excerpt from Velterop's response:
Toll-access publishing denies to the science community the benefit, and ignores the growing necessity, to search, mine and exploit all the available findings using the best tools available. As long as a substantial proportion of research is placed behind toll-access barriers such as operated by Elsevier and others, the ability of scientists to extract knowledge from the literature will be unnecessarily limited. The sooner Open Access becomes the universal method to publish science research findings the sooner will the active research scientists benefit from efficient and effective use of the findings of science.Velterop is the publisher of BioMed Central. Jongejan is CEO of Elsevier's Science & Technology Division. |
|||